Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Report
RA02365
Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, by Product (Normal balloon catheter, Drug eluting balloon catheter, Cutting balloon catheter, Scoring balloon catheter), Delivery Platform (Rapid Exchange (RX) / Monorail balloon catheter, Over-the-wire (OTW) balloon catheter), Compliance (Semi-Compliant, Non-Compliant), Balloon Material (Polyolefin copolymer (POC), Polyethylene (PE), Polyethylene terephthalate (PET)): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market is estimated to surpass $1,672.9 million by 2027, exhibiting a CAGR of 4.2% from 2020 to 2027.
The report offers a thorough analysis of global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market with detailed study of various aspects of the market such as market dynamics, vital segments, major geographies, key players, and competitive landscape.
The report provides a clear picture of the current market situation and future trends of the global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market based on impact of various market dynamics and vital forces influencing the market. The drivers and opportunities in the market contributing to the market growth are acknowledged in the market dynamics. Besides, challenges and restraints that hold potential to hamper the market growth are also premeditated in the global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market. Porter’s five forces analysis is delivered through the report which precisely highlights the effects of key forces on the global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market.
The report offers market size and estimations analyzing global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market through various segments. In addition, the report includes geographical market analysis of these segments. Each segment entailed in the report is studied at regional and country level as well to provide complete coverage of global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market. The report categorizes the global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market into four major geographies including North America, Europe, Asia-Pacific, and LAMEA. These geographies are further sub-categorized into countries to cover percutaneous transluminal coronary angioplasty (ptca) balloon catheter market scenario across in respective regions.
Furthermore, the report covers competitive scenario of the global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market. The key players operating in the global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market are studied in the report to understand their current market position and competitive strengths in the industry. The report profiles 10 key companies. Moreover, the company profiles include various data-points such as company overview, company executives, recent financials of the company, major growth strategies espoused by company, new initiatives and advancements by company to sustain and mend their position in the global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market, and others.
Research Methodology
We offer our clients comprehensive research and analysis based on an extensive variety of factual inputs, which mostly include industry participants’ interviews, reliable statistics, and regional acumen. The in-house market experts play an impactful role in designing analytic models and tools, personalized to the requirements of a market segment. These analytical models and tools sterilize the data and statistics and enrich the accuracy of our advice and recommendations.
For accomplishment of this research report, long hours of discussions and interviews have been conducted, with an extensive range of stakeholders that includes upstream and downstream participants. A number of product type literatures, annual reports, industry releases, and other related documents of key industry contributors have been reviewed, for better understanding of the market. We have executed a mix of primary and secondary research for the market estimates and forecasts. Secondary research formulae the initial phase of our detailed study, where we conduct wide-range data mining, referring to certified data sources such as technical journals, medical journals, independent studies, trade association’s releases, materials published by government and regulatory authorities.
KEY MARKET BENEFITS
- The report is a compilation of detailed information, inputs from industry participants and industry experts across the value chain, and quantitative and qualitative assessment by industry analysts.
- This report provides in-depth analysis of current market trends, governing factors, macro-economic indicators from 2019 to 2027 to identify & understand the prevailing opportunities and the strategic assessment of the growth of the global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market.
- The report maps the qualitative sway of various industry factors on market segments as well as geographies.
- The market estimations and size provided in the report are based on a comprehensive analysis of recent & futuristic key developments in the percutaneous transluminal coronary angioplasty (ptca) balloon catheter market.
- The growth and development strategies adopted by the prominent industry players are enlisted in the report to understand the competitive scenario of the percutaneous transluminal coronary angioplasty (ptca) balloon catheter market.
KEY MARKET SEGMENTS
The global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market is segmented on the basis of following:
- Product: Normal balloon catheter, Drug eluting balloon catheter, Cutting balloon catheter, Scoring balloon catheter
- Delivery Platform: Rapid Exchange (RX) / Monorail balloon catheter, Over-the-wire (OTW) balloon catheter
- Compliance: Semi-Compliant, Non-Compliant
- Balloon Material: Polyolefin copolymer (POC), Polyethylene (PE), Polyethylene terephthalate (PET)
- Region: North America, Europe, Asia Pacific, and LAMEA.
This segment is further sub-segmented into the following regions:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA
KEY MARKET PLAYERS
The global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market is consolidated with the presence of large number of key players. These players focus upon innovation and expansion of product portfolios to acquire a competitive edge in the market space. The report summarizes various aspects of all these key players including financial performance, product portfolio, recent strategic moves & developments, and SWOT analysis.
Players in global percutaneous transluminal coronary angioplasty (ptca) balloon catheter market include:
1. Abbott Laboratories
2. B. Braun Melsungen AG
3. BIOTRONIK SE & Co. KG
4. Boston Scientific Corporation
5. C. R. Bard, Inc.
6. Cardinal Health, Inc.
7. Medtronic plc
8. MicroPort Scientific Corporation
9. Terumo Corporation
10. THE SPECTRANETICS CORPORATION
11. Lepu Medical Technology (Beijing) Co., Ltd.
12. Meril Life Sciences Pvt. Ltd.
13. COOK MEDICAL INC.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By End Use
5.1. Overview
5.2 Normal balloon catheter
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Drug eluting balloon catheter
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Cutting balloon catheter
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Scoring balloon catheter
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Research Dive Exclusive Insights
5.6.1 Market attractiveness
5.6.2 Competition heatmap
-
6. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Grade Type
6.1. Overview
6.2 Rapid Exchange (RX) / Monorail balloon catheter
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Over-the-wire (OTW) balloon catheter
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Research Dive Exclusive Insights
6.4.1 Market attractiveness
6.4.2 Competition heatmap
-
7. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Cell Source
7.1. Overview
7.2 Semi-Compliant
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Non-Compliant
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Research Dive Exclusive Insights
7.4.1 Market attractiveness
7.4.2 Competition heatmap
-
8. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Administration
8.1. Overview
8.2 Polyolefin copolymer (POC)
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 Polyethylene (PE)
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Polyethylene terephthalate (PET)
8.4.1 Definition, key trends, growth factors, and opportunities
8.4.2 Market size analysis, by region, 2020-2027
8.4.3 Market share analysis, by country, 2020-2027
8.5 Research Dive Exclusive Insights
8.5.1 Market attractiveness
8.5.2 Competition heatmap
9. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Region
9.1 North America
9.1.1 U.S
9.1.1.1 Market size analysis, By End Use, 2020-2027
9.1.1.2 Market size analysis, By Grade Type, 2020-2027
9.1.1.3 Market size analysis, By Cell Source, 2020-2027
9.1.1.4 Market size analysis, By Administration, 2020-2027
9.1.2 Canada
9.1.2.1 Market size analysis, By End Use, 2020-2027
9.1.2.2 Market size analysis, By Grade Type, 2020-2027
9.1.2.3 Market size analysis, By Cell Source, 2020-2027
9.1.2.4 Market size analysis, By Administration, 2020-2027
9.1.3 Mexico
9.1.3.1 Market size analysis, By End Use, 2020-2027
9.1.3.2 Market size analysis, By Grade Type, 2020-2027
9.1.3.3 Market size analysis, By Cell Source, 2020-2027
9.1.3.4 Market size analysis, By Administration, 2020-2027
9.1.4 Research Dive Exclusive Insights
9.1.4.1 Market attractiveness
9.1.4.2 Competition heatmap
9.2 Europe
9.2.1 Germany
9.2.1.1 Market size analysis, By End Use, 2020-2027
9.2.1.2 Market size analysis, By Grade Type, 2020-2027
9.2.1.3 Market size analysis, By Cell Source, 2020-2027
9.2.1.4 Market size analysis, By Administration, 2020-2027
9.2.2 UK
9.2.2.1 Market size analysis, By End Use, 2020-2027
9.2.2.2 Market size analysis, By Grade Type, 2020-2027
9.2.2.3 Market size analysis, By Cell Source, 2020-2027
9.2.2.4 Market size analysis, By Administration, 2020-2027
9.2.3 France
9.2.3.1 Market size analysis, By End Use, 2020-2027
9.2.3.2 Market size analysis, By Grade Type, 2020-2027
9.2.3.3 Market size analysis, By Cell Source, 2020-2027
9.2.3.4 Market size analysis, By Administration, 2020-2027
9.2.4 Spain
9.2.4.1 Market size analysis, By End Use, 2020-2027
9.2.4.2 Market size analysis, By Grade Type, 2020-2027
9.2.4.3 Market size analysis, By Cell Source, 2020-2027
9.2.4.4 Market size analysis, By Administration, 2020-2027
9.2.5 Italy
9.2.5.1 Market size analysis, By End Use, 2020-2027
9.2.5.2 Market size analysis, By Grade Type, 2020-2027
9.2.5.3 Market size analysis, By Cell Source, 2020-2027
9.2.5.4 Market size analysis, By Administration, 2020-2027
9.2.6 Rest of Europe
9.2.6.1 Market size analysis, By End Use, 2020-2027
9.2.6.2 Market size analysis, By Grade Type, 2020-2027
9.2.6.3 Market size analysis, By Cell Source, 2020-2027
9.2.6.4 Market size analysis, By Administration, 2020-2027
9.2.7 Research Dive Exclusive Insights
9.2.7.1 Market attractiveness
9.2.7.2 Competition heatmap
9.3 Asia-Pacific
9.3.1 China
9.3.1.1 Market size analysis, By End Use, 2020-2027
9.3.1.2 Market size analysis, By Grade Type, 2020-2027
9.3.1.3 Market size analysis, By Cell Source, 2020-2027
9.3.1.4 Market size analysis, By Administration, 2020-2027
9.3.2 Japan
9.3.2.1 Market size analysis, By End Use, 2020-2027
9.3.2.2 Market size analysis, By Grade Type, 2020-2027
9.3.2.3 Market size analysis, By Cell Source, 2020-2027
9.3.2.4 Market size analysis, By Administration, 2020-2027
9.3.3 India
9.3.3.1 Market size analysis, By End Use, 2020-2027
9.3.3.2 Market size analysis, By Grade Type, 2020-2027
9.3.3.3 Market size analysis, By Cell Source, 2020-2027
9.3.3.4 Market size analysis, By Administration, 2020-2027
9.3.4 Australia
9.3.4.1 Market size analysis, By End Use, 2020-2027
9.3.4.2 Market size analysis, By Grade Type, 2020-2027
9.3.4.3 Market size analysis, By Cell Source, 2020-2027
9.3.4.4 Market size analysis, By Administration, 2020-2027
9.3.5 South Korea
9.3.5.1 Market size analysis, By End Use, 2020-2027
9.3.5.2 Market size analysis, By Grade Type, 2020-2027
9.3.5.3 Market size analysis, By Cell Source, 2020-2027
9.3.5.4 Market size analysis, By Administration, 2020-2027
9.3.6 Rest of Asia-Pacific
9.3.6.1 Market size analysis, By End Use, 2020-2027
9.3.6.2 Market size analysis, By Grade Type, 2020-2027
9.3.6.3 Market size analysis, By Cell Source, 2020-2027
9.3.6.4 Market size analysis, By Administration, 2020-2027
9.3.7 Research Dive Exclusive Insights
9.3.7.1 Market attractiveness
9.3.7.2 Competition heatmap
9.4 LAMEA
9.4.1 Brazil
9.4.1.1 Market size analysis, By End Use, 2020-2027
9.4.1.2 Market size analysis, By Grade Type, 2020-2027
9.4.1.3 Market size analysis, By Cell Source, 2020-2027
9.4.1.4 Market size analysis, By Administration, 2020-2027
9.4.2 Saudi Arabia
9.4.2.1 Market size analysis, By End Use, 2020-2027
9.4.2.2 Market size analysis, By Grade Type, 2020-2027
9.4.2.3 Market size analysis, By Cell Source, 2020-2027
9.4.2.4 Market size analysis, By Administration, 2020-2027
9.4.3 UAE
9.4.3.1 Market size analysis, By End Use, 2020-2027
9.4.3.2 Market size analysis, By Grade Type, 2020-2027
9.4.3.3 Market size analysis, By Cell Source, 2020-2027
9.4.3.4 Market size analysis, By Administration, 2020-2027
9.4.4 South Africa
9.4.4.1 Market size analysis, By End Use, 2020-2027
9.4.4.2 Market size analysis, By Grade Type, 2020-2027
9.4.4.3 Market size analysis, By Cell Source, 2020-2027
9.4.4.4 Market size analysis, By Administration, 2020-2027
9.4.5 Rest of LAMEA
9.4.5.1 Market size analysis, By End Use, 2020-2027
9.4.5.2 Market size analysis, By Grade Type, 2020-2027
9.4.5.3 Market size analysis, By Cell Source, 2020-2027
9.4.5.4 Market size analysis, By Administration, 2020-2027
9.4.6 Research Dive Exclusive Insights
9.4.6.1 Market attractiveness
9.4.6.2 Competition heatmap
10. Competitive Landscape
10.1 Top winning strategies, 2020-2027
10.1.1 By strategy
10.1.2 By year
10.2 Strategic overview
10.3 Market share analysis, 2020-2027
11. Company Profiles
11.1 Abbott Laboratories
11.1.1 Overview
11.1.2 Business segments
11.1.3 Product portfolio
11.1.4 Financial performance
11.1.5 Recent developments
11.1.6 SWOT analysis
11.2 B. Braun Melsungen AG
11.2.1 Overview
11.2.2 Business segments
11.2.3 Product portfolio
11.2.4 Financial performance
11.2.5 Recent developments
11.2.6 SWOT analysis
11.3 BIOTRONIK SE & Co. KG
11.3.1 Overview
11.3.2 Business segments
11.3.3 Product portfolio
11.3.4 Financial performance
11.3.5 Recent developments
11.3.6 SWOT analysis
11.4 Boston Scientific Corporation
11.4.1 Overview
11.4.2 Business segments
11.4.3 Product portfolio
11.4.4 Financial performance
11.4.5 Recent developments
11.4.6 SWOT analysis
11.5 C. R. Bard, Inc.
11.5.1 Overview
11.5.2 Business segments
11.5.3 Product portfolio
11.5.4 Financial performance
11.5.5 Recent developments
11.5.6 SWOT analysis
11.6 Cardinal Health, Inc.
11.6.1 Overview
11.6.2 Business segments
11.6.3 Product portfolio
11.6.4 Financial performance
11.6.5 Recent developments
11.6.6 SWOT analysis
11.7 Medtronic plc
11.7.1 Overview
11.7.2 Business segments
11.7.3 Product portfolio
11.7.4 Financial performance
11.7.5 Recent developments
11.7.6 SWOT analysis
11.8 MicroPort Scientific Corporation
11.8.1 Overview
11.8.2 Business segments
11.8.3 Product portfolio
11.8.4 Financial performance
11.8.5 Recent developments
11.8.6 SWOT analysis
11.9 Terumo Corporation
11.9.1 Overview
11.9.2 Business segments
11.9.3 Product portfolio
11.9.4 Financial performance
11.9.5 Recent developments
11.9.6 SWOT analysis
11.10 THE SPECTRANETICS CORPORATION
11.10.1 Overview
11.10.2 Business segments
11.10.3 Product portfolio
11.10.4 Financial performance
11.10.5 Recent developments
11.10.6 SWOT analysis
11.11 Lepu Medical Technology (Beijing) Co., Ltd.
11.11.1 Overview
11.11.2 Business segments
11.11.3 Product portfolio
11.11.4 Financial performance
11.11.5 Recent developments
11.11.6 SWOT analysis
11.12 Meril Life Sciences Pvt. Ltd.
11.12.1 Overview
11.12.2 Business segments
11.12.3 Product portfolio
11.12.4 Financial performance
11.12.5 Recent developments
11.12.6 SWOT analysis
11.13 COOK MEDICAL INC.
11.13.1 Overview
11.13.2 Business segments
11.13.3 Product portfolio
11.13.4 Financial performance
11.13.5 Recent developments
11.13.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
